Skip to main content

Want a detailed portfolio tracker?

BriaCell Therapeutics Corp - New (BCTX) P/E (2022 - 2026)

BriaCell Therapeutics Corp - New (BCTX) P/E from Aug 1, 2022 to Jul 21, 2026. The TTM BriaCell Therapeutics Corp - New (BCTX) P/E is -0.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BriaCell Therapeutics Corp - New (BCTX)

YearP/EChange
2026-0.35-42.08%
2025-0.61-94.07%
2024-10.27-89.97%
2023-102.35-84.30%
2022-652.06N/A

Comparison BriaCell Therapeutics Corp - New (BCTX) P/E with competitors

BriaCell Therapeutics Corp - New (BCTX) P/E is -0.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.48%
NBYStablecoin Development Corp0.00-101.22%
ENLVEnlivex Ltd0.07-121.20%
FGENFibroGen Inc0.24-168.04%
CHRSCoherus Biosciences Inc0.85-340.53%
FBIOFortress Biotech Inc0.95-369.02%
ORMPOramed Pharmaceuticals Inc1.50-526.06%
AGENAgenus Inc3.01-953.11%
INVAInnoviva Inc3.15-994.05%
VXRTVaxart Inc3.55-1106.22%
CRMDCorMedix Inc3.63-1128.53%
CVACCureVac N.V.4.45-1360.18%
GLPGGalapagos NV4.86-1477.31%
SRPTSarepta Therapeutics Inc4.88-1483.89%
ABEOAbeona Therapeutics Inc5.39-1627.15%
ABUSArbutus Biopharma Corp5.60-1686.15%
ZVRAZevra Therapeutics Inc5.89-1768.81%
SPROSpero Therapeutics Inc6.23-1865.53%
CGENCompugen Ltd6.31-1889.76%
RIGLRigel Pharmaceuticals6.87-2047.97%
SLXNSilexion Therapeutics Corp7.30-2168.16%
OMEROmeros Corporation9.26-2724.51%
AUPHAurinia Pharmaceuticals Inc9.58-2816.98%
PLXProtalix BioTherapeutics Inc10.89-3187.19%
ACADAcadia Pharmaceuticals Inc11.73-3424.60%
TBPHTheravance Biopharma Inc12.26-3575.86%
ADMAAdma Biologics Inc12.42-3620.08%
HRMYHarmony Biosciences Holdings Inc13.82-4017.51%
SABSSAB Biotherapeutics Inc14.14-4107.09%
NAGENiagen Bioscience Inc14.82-4300.39%
INCYIncyte Corp15.82-4585.11%
REGNRegeneron Pharmaceuticals Inc15.86-4594.78%
PBYIPuma Biotechnology Inc17.32-5008.37%
CPRXCatalyst Pharmaceuticals Inc17.44-5043.40%
EXELExelixis Inc17.54-5071.38%
TGTXTG Therapeutics Inc18.97-5476.18%
MDXGMimedx Group Inc20.55-5925.88%
XOMAXOMA Royalty Corp22.87-6584.31%
ARGXArgen X SE24.30-6987.77%
CTMXCytomX Therapeutics Inc24.82-7136.06%
XOMAOXOMA Royalty Corp25.34-7284.51%
HALOHalozyme Therapeutics Inc25.62-7363.57%
XOMAPXOMA Royalty Corp25.67-7376.73%
VRTXVertex Pharmaceuticals Inc27.99-8035.69%
RPRXRoyalty Pharma plc - Class A28.69-8232.08%
SLNOSoleno Therapeutics Inc29.02-8325.00%
ASNDAscendis Pharma A/S30.09-8628.37%
LGNDLigand Pharmaceuticals Inc - Class B37.91-10846.95%
APLSApellis Pharmaceuticals Inc39.02-11161.38%
BMRNBiomarin Pharmaceutical Inc42.21-12065.83%
KRYSKrystal Biotech Inc45.34-12953.55%
ONCBeiGene Ltd69.54-19812.69%
PHARPharming Group N.V.75.03-21367.57%
TECHBio-Techne Corp101.96-29002.24%
VCELVericel Corp109.92-31259.51%
ALNYAlnylam Pharmaceuticals Inc117.96-33539.68%
GMABGenmab140.29-39868.36%
TLXTelix Pharmaceuticals Ltd162.15-46065.63%
CORTCorcept Therapeutics Inc212.86-60438.93%